[HTML][HTML] Diabetic muscular atrophy: molecular mechanisms and promising therapies

Y Shen, M Li, K Wang, G Qi, H Liu, W Wang… - Frontiers in …, 2022 - frontiersin.org
Diabetes mellitus (DM) is a typical chronic disease that can be divided into 2 types,
dependent on insulin deficiency or insulin resistance. Incidences of diabetic complications …

The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy

H Chen, X Huang, M Dong, S Wen… - … Syndrome and Obesity, 2023 - Taylor & Francis
Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …

[HTML][HTML] Nutrition in patients with type 2 diabetes: present knowledge and remaining challenges

ML Petroni, L Brodosi, F Marchignoli, AS Sasdelli… - Nutrients, 2021 - mdpi.com
Unhealthy behaviours, including diet and physical activity, coupled with genetic
predisposition, drive type 2 diabetes (T2D) occurrence and severity; the present review aims …

[HTML][HTML] Management of type 2 diabetes mellitus in elderly patients with frailty and/or sarcopenia

J Sanz-Cánovas, A López-Sampalo… - International journal of …, 2022 - mdpi.com
The life expectancy of the population is increasing worldwide due to improvements in the
prevention, diagnosis, and treatment of diseases. This favors a higher prevalence of type 2 …

[HTML][HTML] The impact of glucose-lowering drugs on sarcopenia in type 2 diabetes: current evidence and underlying mechanisms

E Massimino, A Izzo, G Riccardi, G Della Pepa - Cells, 2021 - mdpi.com
The age-related decrease in skeletal muscle mass together with the loss of muscle power
and function is defined sarcopenia. Mounting evidence suggests that the prevalence of …

[HTML][HTML] Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review

RH Mellen, OS Girotto, EB Marques, LF Laurindo… - Biomedicines, 2023 - mdpi.com
Sarcopenia is a multifactorial condition related to the loss of muscle mass and strength due
to aging, eating habits, physical inactivity, or even caused by another disease. Affected …

High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: a case-control study

J Mittal, A Ghosh, SP Bhatt, S Anoop, IA Ansari… - Diabetes & Metabolic …, 2021 - Elsevier
Abstract Background Post COVID-19 syndrome (PCS) has emerged as a major roadblock in
the recovery of patients infected with SARS-CoV-2. Amongst many symptoms like myalgia …

[HTML][HTML] Ubiquitin-specific proteases (USPs) and metabolic disorders

H Kitamura - International journal of molecular sciences, 2023 - mdpi.com
Ubiquitination and deubiquitination are reversible processes that modify the characteristics
of target proteins, including stability, intracellular localization, and enzymatic activity …

[HTML][HTML] Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study

S Volpe, G Lisco, M Fanelli, D Racaniello… - Frontiers in …, 2023 - frontiersin.org
Background Oral semaglutide is the first glucagon-like peptide-1 receptor agonist (GLP-
1RA) designed for oral administration; it offers a promising opportunity to facilitate an early …

[HTML][HTML] Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus

F Takahashi, Y Hashimoto, A Kaji, R Sakai… - Frontiers in …, 2021 - frontiersin.org
Background Sarcopenia has reportedly been associated with increased risk of mortality in
general populations. However, few studies have investigated the association between …